L
Laure Vincent
Researcher at University of Montpellier
Publications - 81
Citations - 1634
Laure Vincent is an academic researcher from University of Montpellier. The author has contributed to research in topics: Multiple myeloma & Medicine. The author has an hindex of 16, co-authored 60 publications receiving 1161 citations. Previous affiliations of Laure Vincent include French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
Michel Attal,Paul G. Richardson,S. Vincent Rajkumar,Jesús F. San-Miguel,Meral Beksac,Ivan Spicka,Xavier Leleu,Fredrik Schjesvold,Fredrik Schjesvold,Philippe Moreau,Meletios A. Dimopoulos,Jeffrey Shang Yi Huang,Jiri Minarik,Michele Cavo,H. Miles Prince,Sandrine Macé,Kathryn P. Corzo,Frank Campana,Solenn Le-Guennec,Franck Dubin,Kenneth C. Anderson,Vincent Rajkumar,Simon J. Harrison,Wojt Janowski,Ian Kerridge,Andrew Spencer,Michel Delforge,Karel Fostier,Philip Vlummens,Ka Lung Wu,Richard Leblanc,Michel Pavic,Michael Sebag,Roman Hájek,Vladimir Maisnar,Ludek Pour,Henrik Gregersen,Lotfi Benbouker,Denis Caillot,Martine Escoffre-Barbe,Thierry Facon,Laurent Frenzel,Cyrille Hulin,Lionel Karlin,Brigitte Kolb,Brigitte Pegourie,Aurore Perrot,Mourad Tiab,Laure Vincent,Dietger Niederwieser,Achilles Anagnostopoulos,Sosana Delimpasi,Marie Christine Kyrtsonis,Anargyros Symeonidis,Árpád Illés,Gabor Mikala,Zsolt Nagy,Sara Bringen,Paolo Corradini,Ciceri Fabio,Roberto M. Lemoli,Anna Marina Liberati,Chiara Nozzoli,Renato Zambello,Shinsuke Iida,Takashi Ikeda,Satoshi Iyama,Morio Matsumoto,Chihiro Shimazaki,Kazutaka Sunami,Kenshi Suzuki,Michihiro Uchiyama,Youngil Koh,Ki-Hyun Kim,Jae Hoon Lee,Chang-Ki Min,Hillary Blacklock,Hugh Goodman,AJ Neylon,David Simpson,Sebastian Grosicki,Artur Jurczyszyn,Adam Walter-Croneck,Krzysztof Warzocha,Luis Araujo,Claudia Moreira,Vadim A Doronin,Larisa P. Mendeleeva,Vladimir I. Vorobyev,Andrej Vranovsky,Adrian Alegre,Mercedes Gironella,Marta Sonia Gonzalez Perez,Carmen Montes,Enrique M. Ocio,Paula Rodriguez,Mats Hardling,Birgitta Lauri,Ming Chung Wang,Su Peng Yeh,Mutlu Arat,Fatih Demirkan,Zafer Gulbas,Sevgi Kalayoglu Besisik,Ihsan Karadogan,Tulin Tuglular,Ali Ünal,Filiz Vural,Jonathan Sive,Matthew Streetly,Kwee Yong,Jason Tache +111 more
TL;DR: The aim of this study was to determine the progression-free survival benefit of isatuximab plus pomalidomide and dexamethasone compared with pomidine and dexAMethas one in patients with relapsed and refractory multiple myeloma.
Journal ArticleDOI
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia.
Annalisa Ruggeri,M. Labopin,Guillermo Sanz,Simona Piemontese,William Arcese,Almalina Bacigalupo,Didier Blaise,Alberto Bosi,He Huang,Dimitrios Karakasis,Yener Koc,Mauricette Michallet,Alessandra Picardi,Jaime Sanz,Stella Santarone,H Sengeløv,Jordi Sierra,Laure Vincent,Fernanda Volt,Arnon Nagler,Eliane Gluckman,Fabio Ciceri,Vanderson Rocha,Mohamad Mohty +23 more
TL;DR: There were no statistically significant differences on main outcomes after unmanipulated Haplo and UCBT, and both approaches are valid for acute leukemia patients lacking a HLA matched donor.
Journal ArticleDOI
Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO).
Laurence Simon,Aikaterini Fitsiori,Richard Lemal,Jehan Dupuis,Benjamin Carpentier,Laurys Boudin,Anne Corby,Thérèse Aurran-Schleinitz,Lauris Gastaud,Alexis Talbot,Stéphane Leprêtre,Beatrice Mahe,Camille Payet,Carole Soussain,Charlotte Bonnet,Laure Vincent,Severine Lissandre,Raoul Herbrecht,Stéphane Kremer,Véronique Leblond,Luc-Matthieu Fornecker +20 more
TL;DR: It is suggested that Bing-Neel syndrome should be considered in the context of any unexplained neurological symptoms associated with Waldenström macroglobulinemia, and the diagnostic approach should be based on cerebrospinal fluid analysis and magnetic resonance imaging of the brain and spinal axis.
Journal ArticleDOI
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
Michael Loschi,Raphaël Porcher,Fiorenza Barraco,Louis Terriou,Mohamad Mohty,Sophie de Guibert,Beatrice Mahe,Richard Lemal,Pierre-Yves Dumas,Gabriel Etienne,Fabrice Jardin,Bruno Royer,Dominique Bordessoule,Pierre-Simon Rohrlich,Luc Mathieu Fornecker,Celia Salanoubat,Sébastien Maury,Jean-Yves Cahn,Laure Vincent,Thomas Sene,Sophie Rigaudeau,Stéphanie Nguyen,Anne Claire Lepretre,Jean Yves Mary,Jean Yves Mary,Bernadette Corront,Gérard Socié,Régis Peffault de Latour +27 more
TL;DR: It is found that TEs may still occur after the initiation of eculizumab treatment and that previous TEs still have a negative impact on survival, and treatment with eculIZumab improves overall survival in classic PNH patients without increasing the risk of clonal evolution.
Journal ArticleDOI
Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial.
Anne Bergeron,Sylvie Chevret,Angela Granata,Patrice Chevallier,Laure Vincent,Anne Huynh,Reza Tabrizi,Hélène Labussière-Wallet,Marc Bernard,Sylvain Chantepie,Jacques-Olivier Bay,Anne Thiebaut-Bertrand,Sylvain Thepot,Nathalie Contentin,Luc-Matthieu Fornecker,Natacha Maillard,Karine Risso,Ana Berceanu,Didier Blaise,Regis Peffault de la Tour,Jason W. Chien,Valérie Coiteux,Gérard Socié +22 more
TL;DR: Among patients undergoing allogeneic HSCT for hematological malignancy, early administration of azithromycin resulted in worse airflow decline–free survival than did placebo; these findings are limited by early trial termination.